Target Information
| Target General Information | Top | |||||
|---|---|---|---|---|---|---|
| Target ID |
T43025
(Former ID: TTDI01390)
|
|||||
| Target Name |
Alpha-crystallin (CRYA)
|
|||||
| Gene Name |
NO-GeName
|
|||||
| Target Type |
Preclinical target
|
[1] | ||||
| Disease | [+] 1 Target-related Diseases | + | ||||
| 1 | Mycobacterium infection [ICD-11: 1B10-1B21] | |||||
| UniProt ID | ||||||
| Drugs and Modes of Action | Top | |||||
|---|---|---|---|---|---|---|
| Preclinical Drug(s) | [+] 1 Preclinical Drugs | + | ||||
| 1 | 2E9IgA1 | Drug Info | Preclinical | Mycobacterium infection | [2] | |
| Mode of Action | [+] 1 Modes of Action | + | ||||
| Inhibitor | [+] 1 Inhibitor drugs | + | ||||
| 1 | 2E9IgA1 | Drug Info | [3] | |||
| References | Top | |||||
|---|---|---|---|---|---|---|
| REF 1 | Different alpha crystallin expression in human age-related and congenital cataract lens epithelium. BMC Ophthalmol. 2016 May 28;16:67. | |||||
| REF 2 | Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov. 2017 Jul;16(7):457-471. | |||||
| REF 3 | A novel human IgA monoclonal antibody protects against tuberculosis. J Immunol. 2011 Mar 1;186(5):3113-9. | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.